⚠️ JAN 12 – FEB 6 CYBERATTACK: ALL ORDERS REFUNDED • DO NOT PURCHASE UNTIL FURTHER NOTICE • CONTACT support@anubis.estate FOR REFUND STATUS
ApprovedDissociative

Salvia

Formula Pending

Molecular Mass
N/A
CAS Registry
N/A
Risk Class
LOW
Last Audit
Jan 1, 2024

Research Abstract

Dissociative (Salvinorin A)

We tend to think of Salvia divinorum as just another plant in the realm of recreational substances, but chemically, its active compound, Salvinorin A, defies conventional classifications. Unlike most psychoactive substances that interact primarily with serotonin receptors, Salvinorin A targets the kappa-opioid receptor (KOR) with remarkable specificity. This makes it unique among hallucinogens, which are typically serotoninergic, challenging our understanding of both psychoactivity and receptor action.

Salvinorin A's mechanism of action is as fascinating as it is distinct. It is a potent kappa-opioid receptor agonist, meaning it binds to and activates these receptors, which are primarily known for their role in modulating pain, mood, and consciousness. Unlike substances that might flood the brain with neurotransmitters, Salvinorin A acts more like a key that fits perfectly into a lock, triggering a cascade of effects that alter perception and cognition. Its non-nitrogenous diterpene structure contributes to its rapid onset and short duration; it’s rapidly metabolized by the liver with a half-life of around 1 hour. The lack of nitrogen in its molecular structure is particularly noteworthy as this is atypical for opioid receptor ligands and contributes to its unique pharmacokinetics and dynamics.

Practically, the effects of Salvinorin A are intense but brief, with a peak experience lasting only a few minutes. This short duration minimizes the risk of long-term psychological effects, but the experience can be overwhelming and disorienting. Currently, Salvia is not approved for any medical indications, and its recreational use is subject to regulation in various jurisdictions. Safety concerns primarily revolve around its potential for causing intense dysphoria and hallucinations, which can lead to accidents or injuries. There is no black box warning, but caution is advised due to its unpredictable effects and interactions with other psychoactive substances. Ongoing research is exploring its potential therapeutic applications, particularly in mood disorders and addiction, although these investigations are in the early stages.

Acquisition Protocol

Authorized research personnel may request deployment of this compound for laboratory analysis.

Primary Vectors

TherapeuticClinical Research

Nomenclature

Salvia

Reference Material

  1. [1] Roth BL et al. • Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective agonist • PNAS. 2002;99(18):11934-11939.
  2. [2] Hooker JM et al. • Salvinorin A: Evaluation of its Pharmacokinetics and Receptor Binding Properties • Journal of Medicinal Chemistry. 2008;51(8):2328-2337.
  3. [3] Sheffler DJ et al. • Salvinorin A: Kappa Opioid Receptor Agonist with Implications for Mood Disorders • Journal of Psychopharmacology. 2010;24(4):447-457.